Latest Bcl-2 Stories
17 abstracts include data from: NORTH CHICAGO, Ill., May 11, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced 17 abstracts from studies of the company's oncology pipeline are being presented
DUBLIN, April 14, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/c2rl8f/oncogene) has announced the addition of the "Oncogene Inhibitors
- First Patient Dosed in the "Wolverine" Phase II Trial Evaluating ProNAi's BCL2 Targeting DNAi(®) Therapeutic PNT2258 - VANCOUVER, BC and PLYMOUTH, MI, Jan.
Follicular lymphoma, a B cell lymphoma, is an incurable form of non-Hodgkin lymphoma that is diagnosed each year in 120,000 people worldwide.
- Investigators to Present Clinical Trial Findings Evaluating Compounds in Multiple Tumor Types NORTH CHICAGO, Ill., April 23, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that
Walter and Eliza Hall Institute researchers have discovered a promising strategy for treating cancers that are caused by one of the most common cancer-causing changes in cells.
Pancreatic cancer is one of the most deadly and intractable forms of cancer, with a 5-year survival rate of only 6%.
Scientists from Melbourne, Australia recently discovered compounds known as BH3-mimetics currently being researched to treat leukemia may also be effective in treating breast cancer.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.